Cronos Group Inc (NASDAQ:CRON) shares traded -4.10% lower at $1.87 on Wall Street last session.
In accordance with the data, 8 analysts cover Cronos Group Inc (NASDAQ:CRON). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $3.62 and a low of $1.78, we find $2.41. Given the previous closing price of $1.95, this indicates a potential upside of 23.59 percent. CRON stock price is now -6.23% away from the 50-day moving average and -3.64% away from the 200-day moving average. The market capitalization of the company currently stands at $712.68M.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
It has been rated a hold by 4 analysts and a buy by 3. Brokers who have rated the stock have averaged $2.51 as their price target over the next twelve months.
With the price target of $3, Bernstein recently initiated with Mkt Perform rating for Cronos Group Inc (NASDAQ: CRON).
In other news, ADLER JASON MARC, Director bought 37,500 shares of the company’s stock on May 30. The stock was bought for $65,074 at an average price of $1.74. Upon completion of the transaction, the Director now directly owns 1,402,304 shares in the company, valued at $2.62 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 25, Director ADLER JASON MARC bought 100,000 shares of the business’s stock. A total of $179,650 was incurred on buying the stock at an average price of $1.80. This leaves the insider owning 1,376,054 shares of the company worth $2.57 million. Insiders disposed of 230,282 shares of company stock worth roughly $0.43 million over the past 1 year. A total of 47.93% of the company’s stock is owned by insiders.
Cronos Group Inc (NASDAQ: CRON) opened at $1.9600 on Thursday. During the past 12 months, Cronos Group Inc has had a low of $1.64 and a high of $3.62. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 30.03, and a quick ratio of 28.86. The fifty day moving average price for CRON is $1.9942 and a two-hundred day moving average price translates $1.9406 for the stock.
The latest earnings results from Cronos Group Inc (NASDAQ: CRON) was released for Sep, 2023. According to the Drug Manufacturers – Specialty & Generic Company, earnings per share came in at $0, beating analysts’ expectations of -$0.02 by 0.02. This compares to -$0.01 EPS in the same period last year. The net profit margin was -124.25% and return on equity was -9.08% for CRON. The company reported revenue of $24.81 million for the quarter, compared to $20.41 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 21.56 percent. For the current quarter, analysts expect CRON to generate $25.39M in revenue.
Cronos Group Inc(CRON) Company Profile
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones brand in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
